By Regulatory Approvals — FDA approves baricitinib for severe alopecia areata in adolescents 12+ The Clinical Trial Vanguard
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 26, 2026.